Vytrus Biotech, the company specialized in active ingredients derived from plant stem cells for the cosmetic industry, CataloniaBio & HealthTech member, has achieved the approval of its first patent in Europe, United States and Japan.

The patent has been registered under the name of “PEPTIDES AND PHARMACEUTICAL, NUTRACEUTICAL OR VETERINARY COMPOSITIONS FOR HAIR LOSS PREVENTION AND/OR TREATMENT” granted by the European Patent Office, the United States Patent and Trademark Office and the Japan Patent Office.

Europe, USA and Japan have granted the Spanish stock market-listed company with a patent in the field of hair loss prevention and treatment, framed within the proprietary firm’s biotechnology platform called Phyto-Peptidic Fractions. Through this platform, Vytrus has developed several active ingredients from plant stem cells for applications in skincare and haircare. 

The patent covers the activity of one of its cosmetic innovations – Capilia Longa™. This 100% naturalactive from Turmeric stem cells is full of plant growth factors (plant peptides) that re-activate the hair growth, nourish the hair, as well as regenerate the hair follicle in a global approach based on nature and a sustainable and efficient biotechnology.

This triple patent approval is an international recognition of the uniqueness of the Phyto-Peptidic Fractions technology successfully developed by Vytrus. A milestone for the biotechnology company that promotes its guarantee, solidity and confidence in front of its clients, distributors, shareholders and collaborators.